Sanborn Kilcollin Partners’s Medtronic MDT Stock Holding History

Sanborn Kilcollin Partners’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$9.81M	Sell	158,320 -82,477	-34%	-$5.24M	6.86%	5
2014 Q2	$15.4M	Buy	240,797 +1,942	+0.8%	+$118K	7.08%	5
2014 Q1	$14.7M	Buy	238,855 +11,458	+5%	+$667K	7.41%	5
2013 Q4	$13.1M	Sell	227,397 -14,644	-6%	-$830K	6.8%	5
2013 Q3	$12.9M	Buy	242,041 +19,930	+9%	+$1.07M	6.8%	5
2013 Q2	$11.4M	Buy	+222,111	New	+$11M	6.95%	5

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sanborn Kilcollin Partners's MDT Position: Q3 2014 in Review

Sanborn Kilcollin Partners reduced its Medtronic (MDT) stake by 34% in Q3 2014, selling an estimated $5.24M and leaving 158,320 shares worth $9.81M. The position accounts for 6.86% of the portfolio, ranked #5.

Sanborn Kilcollin Partners first reported a position in MDT in Q2 2013 and has held it in 6 quarters since. The position peaked at $15.4M in Q2 2014. 1,134 funds tracked by Wall St. Rank hold MDT as of Q3 2014.

Sanborn Kilcollin Partners held 158,320 shares of Medtronic worth $9.81M as of Q3 2014.
Sanborn Kilcollin Partners sold 82,477 Medtronic shares in Q3 2014, an estimated $5.24M.
Medtronic made up 6.86% of Sanborn Kilcollin Partners's portfolio in Q3 2014, its #5 holding.
Sanborn Kilcollin Partners first reported a position in Medtronic in Q2 2013 and has held it in 6 quarters since.
Sanborn Kilcollin Partners's Medtronic position peaked at $15.4M in Q2 2014.
1,134 funds tracked by Wall St. Rank held Medtronic as of Q3 2014.

Based on Sanborn Kilcollin Partners's 13F filing for Q3 2014, filed 13 Nov 2014.